<SEC-DOCUMENT>0001104659-24-076885-index.html : 20240701 <SEC-HEADER>0001104659-24-076885.hdr.sgml : 20240701 <ACCEPTANCE-DATETIME>20240701170058 ACCESSION NUMBER: 0001104659-24-076885 CONFORMED SUBMISSION TYPE: S-8 PUBLIC DOCUMENT COUNT: 5 FILED AS OF DATE: 20240701 DATE AS OF CHANGE: 20240701 EFFECTIVENESS DATE: 20240701 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Protalix BioTherapeutics, Inc. CENTRAL INDEX KEY: 0001006281 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 650643773 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-8 SEC ACT: 1933 Act SEC FILE NUMBER: 333-280644 FILM NUMBER: 241091575 BUSINESS ADDRESS: STREET 1: 2 UNIVERSITY PLAZA STREET 2: SUITE 100 CITY: HACKENSACK STATE: NJ ZIP: 07601 BUSINESS PHONE: 201-696-9345 MAIL ADDRESS: STREET 1: 2 UNIVERSITY PLAZA STREET 2: SUITE 100 CITY: HACKENSACK STATE: NJ ZIP: 07601 FORMER COMPANY: FORMER CONFORMED NAME: ORTHODONTIX INC DATE OF NAME CHANGE: 19980422 FORMER COMPANY: FORMER CONFORMED NAME: EMBASSY ACQUISITION CORP DATE OF NAME CHANGE: 19960124 </SEC-HEADER> <DOCUMENT> <TYPE>S-8 <SEQUENCE>1 <FILENAME>tm2418481d1_s8.htm <DESCRIPTION>FORM S-8 <TEXT> Document 1 - file: tm2418481d1_s8.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>2 <FILENAME>tm2418481d1_ex5-1.htm <DESCRIPTION>EXHIBIT 5.1 <TEXT> Document 2 - file: tm2418481d1_ex5-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.2 <SEQUENCE>3 <FILENAME>tm2418481d1_ex23-2.htm <DESCRIPTION>EXHIBIT 23.2 <TEXT> Document 3 - file: tm2418481d1_ex23-2.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-FILING FEES <SEQUENCE>4 <FILENAME>tm2418481d1_ex-filingfees.htm <DESCRIPTION>EX-FILING FEES <TEXT> Document 4 - file: tm2418481d1_ex-filingfees.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>tm2418481d1_ex5-1img001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 5 - file: tm2418481d1_ex5-1img001.jpg
</DOCUMENT> </SEC-DOCUMENT>